MENU
HALO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Halozyme Therapeutics (HALO) Ownership - Who owns Halozyme Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6B
P/E Ratio
15.62
Total Cash
666.31M
Projected Growth
N/A
Total Debt
1.5B
Revenue
947.36M
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash/Share
5.24
Total Debt/Equity
74.60
Revenue/Share
7.29 USD as % of share price
Fundamentals
HALO
Capitalization
6B
P/E Ratio
15.62
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash
666M
Total Cash/Share
5.24
Total Debt
1.5B
Total Debt/Equity
74.60
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.29%
Revenue
947M
ROE
N/A
Book Value
453M
P/B Ratio
13.25
Cash Flow
N/A
Earnings
3.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
127K
Current Ratio
10.36
Current Revenue Per Employee
777705.10
Dividends Per Share - Security
N/A
EBITDA
580M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.96
Revenue To Assets
19.57
Shares Held By Institutions
13.7B
Shares Outstanding - Current
127M
Total Liabilities
1.67B
Total Volume MTD
N/A
Value
-1
Gain YTD
27.597
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com